Controversies in Non Muscle Invasive Bladder Cancer
0 Views
administrator
07/08/23
Siamak Daneshmand, MD, reports on recent controversies in non-muscle invasive bladder cancer (NMIBC) regarding chemotherapy options for reducing post-transurethral resection (TUR) recurrences and active surveillance for low-grade patients, as well as alternatives to cystectomy in high-grade patients.
In this video, Dr. Daneshmand discloses the thesis of the discussion he led during the 2018 Future Directions in Urology Symposium (FDUS).
-
Category
Show more
Facebook Comments
No comments found